nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE4C—tongue—salivary gland cancer	0.0811	0.251	CbGeAlD
Flavoxate—PDE8B—neck—salivary gland cancer	0.0503	0.156	CbGeAlD
Flavoxate—PDE7A—lymphoid tissue—salivary gland cancer	0.0379	0.118	CbGeAlD
Flavoxate—PDE7B—lymph node—salivary gland cancer	0.0187	0.0579	CbGeAlD
Flavoxate—PDE4B—parotid gland—salivary gland cancer	0.0176	0.0547	CbGeAlD
Flavoxate—PDE4B—saliva-secreting gland—salivary gland cancer	0.0169	0.0523	CbGeAlD
Flavoxate—CHRM1—parotid gland—salivary gland cancer	0.0159	0.0494	CbGeAlD
Flavoxate—CHRM1—saliva-secreting gland—salivary gland cancer	0.0153	0.0473	CbGeAlD
Flavoxate—PDE8B—lymph node—salivary gland cancer	0.0149	0.0461	CbGeAlD
Flavoxate—PDE8A—lymph node—salivary gland cancer	0.0134	0.0415	CbGeAlD
Flavoxate—PDE4D—lymph node—salivary gland cancer	0.0121	0.0376	CbGeAlD
Flavoxate—PDE4B—lymphoid tissue—salivary gland cancer	0.0113	0.0352	CbGeAlD
Flavoxate—PDE4A—lymph node—salivary gland cancer	0.0107	0.0333	CbGeAlD
Flavoxate—PDE4B—lymph node—salivary gland cancer	0.0064	0.0198	CbGeAlD
Flavoxate—PDE4B—Signaling by GPCR—MC3R—salivary gland cancer	0.00216	0.00319	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—WNT5B—salivary gland cancer	0.00211	0.00312	CbGpPWpGaD
Flavoxate—PDE4D—G Protein Signaling Pathways—HRAS—salivary gland cancer	0.00207	0.00306	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL17RD—salivary gland cancer	0.00204	0.00301	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—FGF16—salivary gland cancer	0.00198	0.00293	CbGpPWpGaD
Flavoxate—PDE4A—G Protein Signaling Pathways—HRAS—salivary gland cancer	0.00197	0.00291	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TOP2A—salivary gland cancer	0.00194	0.00287	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MAML2—salivary gland cancer	0.00193	0.00285	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MAML2—salivary gland cancer	0.00193	0.00285	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00189	0.00278	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00189	0.00278	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MAML3—salivary gland cancer	0.00187	0.00275	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—FGF16—salivary gland cancer	0.00184	0.00272	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—WNT5B—salivary gland cancer	0.00184	0.00271	CbGpPWpGaD
Flavoxate—PDE4B—G Protein Signaling Pathways—HRAS—salivary gland cancer	0.00183	0.0027	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—MC3R—salivary gland cancer	0.00181	0.00267	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—MC3R—salivary gland cancer	0.00178	0.00263	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL17RD—salivary gland cancer	0.00178	0.00262	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—WNT5B—salivary gland cancer	0.00175	0.00258	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MAML2—salivary gland cancer	0.00172	0.00254	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL17RD—salivary gland cancer	0.00169	0.00249	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00168	0.00248	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MC3R—salivary gland cancer	0.00166	0.00245	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—JAG1—salivary gland cancer	0.00165	0.00244	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—JAG1—salivary gland cancer	0.00165	0.00244	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—FGFR4—salivary gland cancer	0.00164	0.00243	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—FGFR4—salivary gland cancer	0.00164	0.00243	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAML3—salivary gland cancer	0.00162	0.0024	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—WNT5B—salivary gland cancer	0.00162	0.00239	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—FBXW7—salivary gland cancer	0.00162	0.00239	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—FBXW7—salivary gland cancer	0.00162	0.00239	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MAML2—salivary gland cancer	0.0016	0.00236	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ST3GAL4—salivary gland cancer	0.0016	0.00236	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL17RD—salivary gland cancer	0.00156	0.00231	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00156	0.00231	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—MAP2K2—salivary gland cancer	0.00155	0.00229	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAML3—salivary gland cancer	0.00155	0.00228	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—MAP2K2—salivary gland cancer	0.00153	0.00226	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—JAG1—salivary gland cancer	0.00147	0.00217	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—FGFR4—salivary gland cancer	0.00147	0.00216	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—DTX4—salivary gland cancer	0.00145	0.00215	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MC3R—salivary gland cancer	0.00145	0.00214	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—FBXW7—salivary gland cancer	0.00144	0.00213	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAML3—salivary gland cancer	0.00143	0.00211	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00139	0.00206	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MC3R—salivary gland cancer	0.00138	0.00203	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—JAG1—salivary gland cancer	0.00137	0.00202	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—FOXO3—salivary gland cancer	0.00136	0.00201	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—FOXO3—salivary gland cancer	0.00136	0.00201	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—FGFR4—salivary gland cancer	0.00136	0.00201	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—FBXW7—salivary gland cancer	0.00134	0.00198	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00133	0.00196	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MC3R—salivary gland cancer	0.00127	0.00188	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—DTX4—salivary gland cancer	0.00126	0.00187	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00123	0.00181	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—FOXO3—salivary gland cancer	0.00122	0.00179	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—DTX4—salivary gland cancer	0.0012	0.00178	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—FGF16—salivary gland cancer	0.0012	0.00177	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—salivary gland cancer	0.00116	0.00171	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—FOXO3—salivary gland cancer	0.00113	0.00167	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—DTX4—salivary gland cancer	0.00111	0.00164	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MAP2K2—salivary gland cancer	0.00111	0.00164	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MAP2K2—salivary gland cancer	0.00111	0.00164	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.0011	0.00162	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—FGF16—salivary gland cancer	0.00105	0.00154	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MAML2—salivary gland cancer	0.00104	0.00154	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00104	0.00154	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00103	0.00152	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—MC3R—salivary gland cancer	0.00102	0.00151	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00102	0.0015	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—MC3R—salivary gland cancer	0.00101	0.00149	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FGF16—salivary gland cancer	0.000996	0.00147	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000993	0.00147	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—MC3R—salivary gland cancer	0.000927	0.00137	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000923	0.00136	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FGF16—salivary gland cancer	0.000921	0.00136	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—MC3R—salivary gland cancer	0.000915	0.00135	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000913	0.00135	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000913	0.00135	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAML2—salivary gland cancer	0.000909	0.00134	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—JAG1—salivary gland cancer	0.000891	0.00132	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—FGFR4—salivary gland cancer	0.000888	0.00131	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000886	0.00131	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—FBXW7—salivary gland cancer	0.000873	0.00129	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAML2—salivary gland cancer	0.000865	0.00128	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000844	0.00125	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CREBBP—salivary gland cancer	0.000827	0.00122	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CREBBP—salivary gland cancer	0.000827	0.00122	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000813	0.0012	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAML2—salivary gland cancer	0.0008	0.00118	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000781	0.00115	CbGpPWpGaD
Flavoxate—PDE8B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000777	0.00115	CbGpPWpGaD
Flavoxate—PDE8A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000777	0.00115	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—JAG1—salivary gland cancer	0.000776	0.00115	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—FGFR4—salivary gland cancer	0.000773	0.00114	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—FBXW7—salivary gland cancer	0.00076	0.00112	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000756	0.00112	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000748	0.0011	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—JAG1—salivary gland cancer	0.000739	0.00109	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CREBBP—salivary gland cancer	0.000737	0.00109	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—FOXO3—salivary gland cancer	0.000737	0.00109	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FGFR4—salivary gland cancer	0.000736	0.00109	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FBXW7—salivary gland cancer	0.000724	0.00107	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000706	0.00104	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000706	0.00104	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—WNT5B—salivary gland cancer	0.000695	0.00103	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000693	0.00102	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—WNT5B—salivary gland cancer	0.000686	0.00101	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CREBBP—salivary gland cancer	0.000686	0.00101	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—JAG1—salivary gland cancer	0.000683	0.00101	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FGFR4—salivary gland cancer	0.000681	0.001	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL17RD—salivary gland cancer	0.000672	0.000991	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FBXW7—salivary gland cancer	0.00067	0.000988	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL17RD—salivary gland cancer	0.000663	0.000979	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—HRAS—salivary gland cancer	0.000653	0.000964	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—HRAS—salivary gland cancer	0.000653	0.000964	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—PTEN—salivary gland cancer	0.000649	0.000958	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000644	0.000951	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—FOXO3—salivary gland cancer	0.000641	0.000947	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000629	0.000928	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—EP300—salivary gland cancer	0.000619	0.000913	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAML3—salivary gland cancer	0.000614	0.000907	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—CCND1—salivary gland cancer	0.000612	0.000904	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—CCND1—salivary gland cancer	0.000612	0.000904	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FOXO3—salivary gland cancer	0.00061	0.000901	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAML3—salivary gland cancer	0.000606	0.000895	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MAP2K2—salivary gland cancer	0.000601	0.000888	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—PTEN—salivary gland cancer	0.000591	0.000872	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—PTEN—salivary gland cancer	0.000591	0.000872	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000585	0.000863	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—HRAS—salivary gland cancer	0.000582	0.000859	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.000581	0.000858	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	0.000574	0.000847	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FOXO3—salivary gland cancer	0.000565	0.000834	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EP300—salivary gland cancer	0.000564	0.000832	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EP300—salivary gland cancer	0.000564	0.000832	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MC3R—salivary gland cancer	0.000547	0.000808	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—CCND1—salivary gland cancer	0.000546	0.000806	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—HRAS—salivary gland cancer	0.000541	0.000799	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MC3R—salivary gland cancer	0.00054	0.000798	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000527	0.000778	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—PTEN—salivary gland cancer	0.000527	0.000777	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAP2K2—salivary gland cancer	0.000524	0.000773	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00052	0.000768	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—CCND1—salivary gland cancer	0.000507	0.000749	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EP300—salivary gland cancer	0.000502	0.000741	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000498	0.000736	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NOTCH1—salivary gland cancer	0.000493	0.000727	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PTEN—salivary gland cancer	0.00049	0.000723	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.000485	0.000716	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DTX4—salivary gland cancer	0.000478	0.000706	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DTX4—salivary gland cancer	0.000472	0.000697	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EP300—salivary gland cancer	0.000467	0.000689	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000461	0.000681	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CREBBP—salivary gland cancer	0.000447	0.00066	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TP53—salivary gland cancer	0.000443	0.000654	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.000434	0.00064	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOTCH1—salivary gland cancer	0.000429	0.000633	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.00042	0.000619	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—PIK3CA—salivary gland cancer	0.000417	0.000615	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—PIK3CA—salivary gland cancer	0.000417	0.000615	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000408	0.000603	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TP53—salivary gland cancer	0.000403	0.000595	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TP53—salivary gland cancer	0.000403	0.000595	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000401	0.000592	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGF16—salivary gland cancer	0.000396	0.000584	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGF16—salivary gland cancer	0.000391	0.000577	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CREBBP—salivary gland cancer	0.000389	0.000574	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—HRAS—salivary gland cancer	0.000386	0.000569	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—HRAS—salivary gland cancer	0.000386	0.000569	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000381	0.000563	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000378	0.000558	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—PIK3CA—salivary gland cancer	0.000372	0.000548	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CREBBP—salivary gland cancer	0.00037	0.000547	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000365	0.000539	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—salivary gland cancer	0.000359	0.000531	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—HRAS—salivary gland cancer	0.000353	0.00052	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000348	0.000513	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PIK3CA—salivary gland cancer	0.000345	0.00051	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAML2—salivary gland cancer	0.000344	0.000507	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HRAS—salivary gland cancer	0.000344	0.000507	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CREBBP—salivary gland cancer	0.000343	0.000506	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAML2—salivary gland cancer	0.000339	0.000501	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000335	0.000495	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—salivary gland cancer	0.000334	0.000493	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000332	0.00049	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000331	0.000489	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCND1—salivary gland cancer	0.000331	0.000488	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000322	0.000475	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HRAS—salivary gland cancer	0.00032	0.000472	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PTEN—salivary gland cancer	0.000319	0.000471	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000316	0.000466	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HRAS—salivary gland cancer	0.000307	0.000453	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EP300—salivary gland cancer	0.000304	0.000449	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—JAG1—salivary gland cancer	0.000294	0.000433	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGFR4—salivary gland cancer	0.000292	0.000431	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000292	0.000431	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HRAS—salivary gland cancer	0.000292	0.000431	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—JAG1—salivary gland cancer	0.00029	0.000428	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGFR4—salivary gland cancer	0.000289	0.000426	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCND1—salivary gland cancer	0.000288	0.000425	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FBXW7—salivary gland cancer	0.000288	0.000424	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FBXW7—salivary gland cancer	0.000284	0.000419	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PTEN—salivary gland cancer	0.000278	0.00041	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCND1—salivary gland cancer	0.000274	0.000404	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HRAS—salivary gland cancer	0.00027	0.000399	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EP300—salivary gland cancer	0.000265	0.000391	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PTEN—salivary gland cancer	0.000264	0.00039	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCND1—salivary gland cancer	0.000253	0.000374	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EP300—salivary gland cancer	0.000252	0.000372	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PTEN—salivary gland cancer	0.000245	0.000361	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FOXO3—salivary gland cancer	0.000243	0.000358	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FOXO3—salivary gland cancer	0.000239	0.000353	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EP300—salivary gland cancer	0.000233	0.000344	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PIK3CA—salivary gland cancer	0.000225	0.000332	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—salivary gland cancer	0.000218	0.000321	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HRAS—salivary gland cancer	0.000208	0.000307	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000198	0.000292	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CA—salivary gland cancer	0.000196	0.000289	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000196	0.000289	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—salivary gland cancer	0.00019	0.00028	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CA—salivary gland cancer	0.000187	0.000275	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HRAS—salivary gland cancer	0.000181	0.000268	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—salivary gland cancer	0.00018	0.000266	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CA—salivary gland cancer	0.000173	0.000255	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HRAS—salivary gland cancer	0.000173	0.000255	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—salivary gland cancer	0.000167	0.000246	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000162	0.00024	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH1—salivary gland cancer	0.00016	0.000236	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HRAS—salivary gland cancer	0.00016	0.000236	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CREBBP—salivary gland cancer	0.000147	0.000217	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CREBBP—salivary gland cancer	0.000145	0.000214	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000138	0.000204	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000136	0.000201	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000125	0.000185	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000124	0.000183	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HRAS—salivary gland cancer	0.000116	0.000171	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HRAS—salivary gland cancer	0.000115	0.000169	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCND1—salivary gland cancer	0.000109	0.000161	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCND1—salivary gland cancer	0.000107	0.000159	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTEN—salivary gland cancer	0.000105	0.000155	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTEN—salivary gland cancer	0.000104	0.000153	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EP300—salivary gland cancer	0.0001	0.000148	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EP300—salivary gland cancer	9.89e-05	0.000146	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CA—salivary gland cancer	7.41e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CA—salivary gland cancer	7.32e-05	0.000108	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—salivary gland cancer	7.17e-05	0.000106	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—salivary gland cancer	7.08e-05	0.000104	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HRAS—salivary gland cancer	6.86e-05	0.000101	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HRAS—salivary gland cancer	6.77e-05	9.99e-05	CbGpPWpGaD
